|
SABS Sab Biotherapeutics Inc 1833214 |
| Balance Sheet |
|
Current Assets
|
32,537,040 |
|
Assets
|
53,797,183 |
|
Current Liabilities
|
8,816,174 |
|
Liabilities
|
16,894,566 |
|
Equity
|
36,902,617 |
|
Shares Out
|
9,229,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-24,759,821 |
|
Investing Cash Flow
|
-21,293,033 |
| Market Analysis |
Market Cap
|
25,426,645 |
|
Price
|
1.56 |
|
BVPS
|
4.00 |
|
PB
|
0.38 |
|
EPS
|
-5.69 |
|
PS
|
5.26 |
|
FCF
|
-46,052,854 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SABS documents filed with the SEC.
SABS Filings
Clear
